Inventor · disambiguated record
Pedro Santamaria
Also filed as: SANTAMARIA PEDRO
19 granted patents·21 pending applications·251 citations·filing 1991–2024
95Inventor score
Top patents by PatentIndex Score
40 records- 0195US10080808B2Methods and compositions for treating multiple sclerosis and related disordersUTI LP·Filed 2017·Granted Sep 25, 2018·8 cites·20 claims
- 0295US9603948B2Methods and compositions for treating multiple sclerosis and related disordersUTI LIMITED PARTNERSHIP·Filed 2015·Granted Mar 28, 2017·8 cites·24 claims
- 0395US8354110B2Compositions and methods for the prevention and treatment of autoimmune conditionsUTI LIMITED PARTNERSHIP·Filed 2008·Granted Jan 15, 2013·36 cites·21 claims
- 0493US10905773B2Methods and compositions for treating multiple sclerosis and related disordersUTI LP·Filed 2018·Granted Feb 2, 2021·4 cites·31 claims
- 0592US11338024B2Methods and compositions for sustained immunotherapyUTI LP·Filed 2018·Granted May 24, 2022·4 cites·16 claims
- 0692US11000596B2Compositions and methods for the prevention and treatment of cancerUTI LP·Filed 2018·Granted May 11, 2021·4 cites·20 claims
- 0791US10485882B2Nanoparticle compositions for sustained therapyUTI LP·Filed 2016·Granted Nov 26, 2019·9 cites·11 claims
- 0890US12011480B2Nanoparticle compositions for sustained therapyUTI LP·Filed 2016·Granted Jun 18, 2024·3 cites·8 claims
- 0990US10124045B2Methods and compositions for sustained immunotherapyUTI LP·Filed 2014·Granted Nov 13, 2018·10 cites·11 claims
- 1089US10172955B2Compositions and methods for the prevention and treatment of cancerUTI LP·Filed 2016·Granted Jan 8, 2019·6 cites·25 claims
- 1188US9511151B2Compositions and methods for the prevention and treatment of cancerSANTAMARIA PEDRO·Filed 2011·Granted Dec 6, 2016·16 cites·19 claims
- 1288US2025121043A1Compositions and methods for the prevention and treatment of autoimmune conditionsUTI LP·Filed 2024·Application pending·0 cites
- 1386US10988516B2Methods and compositions for treating inflammationUTI LP·Filed 2013·Granted Apr 27, 2021·3 cites·16 claims
- 1481US12397038B2Ubiquitous antigens for treatment of autoimmune or inflammatory diseasesUTI LP·Filed 2018·Granted Aug 26, 2025·1 cites·16 claims
- 1581US2024299536A1Nanoparticle compositions for sustained therapyUTI LP·Filed 2024·Application pending·0 cites
- 1677US2024201171A1Assay to measure the potency of receptor-ligand interactions in nanomedicinesUTI LP·Filed 2023·Application pending·0 cites
- 1777US2025051420A1RECOMBINANT pMHC CLASS II MOLECULESUTI LP·Filed 2024·Application pending·0 cites
- 1875US2023355730A1Methods for treating autoimmune disease using biocompatible bioabsorbable nanospheresUTI LP·Filed 2022·Application pending·0 cites
- 1975US2022401534A1Methods and compositions for sustained immunotherapyUTI LP·Filed 2022·Application pending·0 cites
- 2074US2021145949A1Compositions and methods for the prevention and treatment of autoimmune conditionsUTI LP·Filed 2020·Application pending·0 cites
- 2170US2021205470A1Methods and compositions for treating multiple sclerosis and related disordersUTI LP·Filed 2020·Application pending·0 cites
- 2268US12448419B2Methods and compositions for treating inflammationUTI LP·Filed 2021·Granted Oct 21, 2025·0 cites·18 claims
- 2368US5578443ADNA sequence-based HLA typing methodUNIV MINNESOTA·Filed 1991·Granted Nov 26, 1996·47 cites·39 claims
- 2467US5972604ADNA sequence-based HLA typing methodUNIV MINNESOTA·Filed 1996·Granted Oct 26, 1999·29 cites·27 claims
- 2563US2017333540A1Compositions and methods for the prevention and treatment of autoimmune conditionsUTI LP·Filed 2017·Application pending·0 cites
- 2661US5424184ADNA sequence-based HLA class I typing methodUNIV MINNESOTA·Filed 1991·Granted Jun 13, 1995·30 cites·14 claims
- 2761US2013302421A1Compositions and methods for the prevention and treatment of autoimmune conditionsGEN HOSPITAL CORP·Filed 2012·Application pending·0 cites
- 2860US2022387583A1Recombinant pmhc moleculesUTI LP·Filed 2022·Application pending·0 cites
- 2960US2016271237A1Compositions and methods for the prevention and treatment of autoimmune conditionsUTI LIMITED PARTNERSHIP·Filed 2016·Application pending·0 cites
- 3060US2022089682A1Methods of treating liver diseaseUTI LP·Filed 2021·Application pending·0 cites
- 3159US2020057048A1Assay to measure the potency of receptor-ligand interactions in nanomedicinesUTI LP·Filed 2018·Application pending·0 cites
- 3259US2022211868A1Nanoparticles comprising non-classical mhc and uses thereofUTI LP·Filed 2021·Application pending·0 cites
- 3357US2019134171A1Methods for treating autoimmune disease using biocompatible bioabsorbable nanospheresUTI LP·Filed 2018·Application pending·0 cites
- 3456US2011059121A1Compositions and methods for the prevention and treatment of autoimmune conditionsUTI LIMITED PARTNERSHIP·Filed 2010·Application pending·0 cites
- 3555US5629149ADNA sequence-based HLA typing methodUNIV MINNESOTA·Filed 1993·Granted May 13, 1997·20 cites·36 claims
- 3649US5593830ADNA sequence-based HLA class I typing methodUNIV MINNESOTA·Filed 1994·Granted Jan 14, 1997·13 cites·19 claims
- 3749US2018127481A1RECOMBINANT pMHC CLASS II MOLECULESUTI LP·Filed 2017·Application pending·0 cites
- 3848US2012093934A1Methods for treating autoimmune disease using biocompatible bioabsorbable nanospheresSANTAMARIA PEDRO·Filed 2011·Application pending·0 cites
- 3943US2014105980A1Methods and compositions for treating multiple sclerosis and related disordersUTI LIMITED PARTNERSHIP·Filed 2013·Application pending·0 cites
- 4041US2015250871A1Methods and compositions for treating multiple sclerosis and related disordersUTI LIMITED PARTNERSHIP·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →